Nemours Children’s Health System buys 3rd EOS imagine device — 5 details

Paris-based EOS imaging has sold an EOS x-ray system to Orlando, Fla.-based Nemours Children’s Hospital after two previous sales to the Jacksonville, Fla.-based health system.

Advertisement

Here are five things to know:

 

1. The first two EOS systems were first purchased by Wilmington, Del.-based Nemours Alfred I. duPont Hospital for Children and Jacksonville, Fla.-based Nemours Children’s Specialty Care.

 

2. The EOS imaging emits less radiation exposure than other x-ray equipment and offers better quality images of the spine and limbs in a standing position.

 

3. The seconds-long process gives physicians the chance to view and study the spine in three different positions.

 

4. EOS CEO Marie Meynadier said, “Nemours has been at the forefront of advocating low dose 3D imaging, and the Wilmington location was also recently the first in the U.S. to use our new EOS chair for non-ambulatory patient imaging.”

 

5. Nemours Children’s Health System operates clinics in Delaware, Florida, Georgia, Maryland, New Jersey and Pennsylvania.

 

More device articles:
Consensus launches wearable post-surgical device

SI-Bone launches SI Joint Women’s Health Initiative — 4 observations

Boston Scientific: device tax suspension added over 2K jobs — 5 takeaways

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.